$0.00317
-0.0632-95.22%
Last update: Nov 10, 9:35 AM
PETROS PHARM INC by Petros Pharmaceuticals, Inc.
PTPIOTCPK
PETROS PHARM INC by Petros Pharmaceuticals fell 84.3% from $0.02 to $0.00, behind the S&P 500's +10.5%. Its worst day was Oct 1 (−51.5%), and its low came Oct 26 at $0.00.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.03 was reported on $0.00 revenue.
−1.0% · S&P 500 0.0%
PETROS PHARM INC by Petros Pharmaceuticals shares rose 32.5%, while the S&P 500 fell 0.7%.
Story events cover the past 12 months · Times ET
+32.5% · S&P 500 −0.7%
EPS of $0.44 was reported on $0.00 revenue.
+13.6% · S&P 500 +0.2%
EPS of $-0.03 was reported on $0.00 revenue.
−5.6% · S&P 500 +0.8%
EPS of $-0.30 was reported on $0.00 revenue.
−20.6% · S&P 500 −0.2%
PETROS PHARM INC by Petros Pharmaceuticals shares rose 38.9%, while the S&P 500 fell 0.7%.
+38.9% · S&P 500 −0.7%
PETROS PHARM INC by Petros Pharmaceuticals shares fell 34.2%, while the S&P 500 rose 0.1%.
−34.2% · S&P 500 +0.1%
PETROS PHARM INC by Petros Pharmaceuticals shares fell 51.5%, while the S&P 500 rose 0.2%.
−51.5%, the year's worst day, on 1M shares, the year's heaviest volume · S&P 500 +0.2%
PETROS PHARM INC by Petros Pharmaceuticals closed at its lowest level of the year, 90.8% below where the year started.
−9.5% · S&P 500 +0.7%
PETROS PHARM INC by Petros Pharmaceuticals shares fell 40.0%, while the S&P 500 rose 0.3%.
−40.0% · S&P 500 +0.3%
Where it ended: a close of $0.00 on Nov 9, 2026.
Nothing in the past 12 months.
All PTPI analyst actionsNothing in the past 12 months.
All PTPI dividend historyNothing in the past 12 months.
All PTPI news
